ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY
申请人:ABBOTT LABORATORIES
公开号:EP0595995A1
公开(公告)日:1994-05-11
EP0595995A4
申请人:——
公开号:EP0595995A4
公开(公告)日:1994-08-24
ARYLAMIDOALKYL- AND ARYLAMINOALKYL-N-HYDROXYUREA COMPOUNDS AND -N-HYDROXYFORMAMIDE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY
申请人:ABBOTT LABORATORIES
公开号:EP0595995B1
公开(公告)日:1997-01-15
US5514702A
申请人:——
公开号:US5514702A
公开(公告)日:1996-05-07
[EN] ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY
申请人:ABBOTT LABORATORIES
公开号:WO1993002037A1
公开(公告)日:1993-02-04
(EN) The present invention provides certain (substituted carbocyclic aryl)amidoalkyl- and (substituted heterocyclic aryl)amidoalkyl-N-Hydroxy urea compounds which inhibit lipoxygenase enzyme activity and are thus useful in the treatment of allergic and inflammatory disease states.(FR) Cette invention concerne certains composés d'amidoalkyl-N-hydroxy urée (à substitution aryle carbocyclique) et d'amidoalkyle-N-hydroxy urée (à substitution aryle hétérocyclique) qui inhibent l'activité de la lipoxygénase et qui sont utiles dans le traitement des états pathologiques allergiques et inflammatoires.